InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $1.215 0.055 (4.33%)+

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$38 Notice of Extraordinary General Meeting/Proxy Form 20 Aug 2024 8:25AM $0.012 $1.215 risen by 10,025%
$38 Significant Growth in Commercial Treatment Sales in Q4 FY24 15 Aug 2024 10:13AM $0.010 $1.215 risen by 12,050%
$38 Successful Treatment with OncoSil Device in Turkiye 15 Aug 2024 10:05AM $0.010 $1.215 risen by 12,050%
$38 Ceasing to be a substantial holder SC 14 Aug 2024 5:02PM $0.010 $1.215 risen by 12,050%
$38 Prospectus 7 Aug 2024 9:27AM $0.012 $1.215 risen by 10,025%
$38 Application for quotation of securities - OSL 7 Aug 2024 9:08AM $0.012 $1.215 risen by 10,025%
$38 Notice of Initial Substantial Holding from SOL 31 Jul 2024 5:14PM $0.014 $1.215 risen by 8,578.57%
$38 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2024 10:18AM $0.013 $1.215 risen by 9,246.15%
$38 Becoming a substantial holder from PCG 30 Jul 2024 2:56PM $0.011 $1.215 risen by 10,945.45%
$38 Notice under section 708A 29 Jul 2024 8:43AM $0.009 $1.215 risen by 13,400%
$38 Application for quotation of securities - OSL 29 Jul 2024 8:40AM $0.009 $1.215 risen by 13,400%
$38 Proposed issue of securities - OSL 25 Jul 2024 9:28AM $0.009 $1.215 risen by 13,400%
$38 Proposed issue of securities - OSL 25 Jul 2024 9:25AM $0.009 $1.215 risen by 13,400%
$38 Australian institution to invest $2.7 million in OSL 25 Jul 2024 9:19AM $0.009 $1.215 risen by 13,400%
$38 Investor Presentation 23 Jul 2024 3:36PM $0.008 $1.215 risen by 15,087.50%
$38 Peter Hall to be appointed Non-Executive Director (addendum) 15 Jul 2024 11:02AM $0.007 $1.215 risen by 17,257.14%
$38 Director Appointment/Resignation PH 15 Jul 2024 9:09AM $0.007 $1.215 risen by 17,257.14%
$38 Letter to Short Dated Option Holders 12 Jul 2024 9:14AM $0.007 $1.215 risen by 17,257.14%
$38 OSL Short Dated Options Range of Units and Top 20 Holders 10 Jul 2024 12:37PM $0.006 $1.215 risen by 20,150%
$38 Application for quotation of securities - OSL 10 Jul 2024 12:36PM $0.006 $1.215 risen by 20,150%
$38 Notification regarding unquoted securities - OSL 3 Jul 2024 6:04PM n/a $1.215 n/a
$38 Application for quotation of securities - OSL 3 Jul 2024 6:00PM n/a $1.215 n/a
$38 Notification regarding unquoted securities - OSL 24 Jun 2024 4:23PM $0.005 $1.215 risen by 24,200%
$38 Proposed issue of securities - OSL 21 Jun 2024 4:11PM $0.005 $1.215 risen by 24,200%
$38 5th patient is treated in PANCOSIL trial 11 Jun 2024 8:59AM $0.005 $1.215 risen by 24,200%

226 - 250 of 793 results

Page 10 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.